Search

Could you take on an adventure of a lifetime for Retina UK and take part in the Camino de Santiago, across Spain in September 2026?

• Walks & Treks
• United Kingdom

Could you take on Mount Kilimanjaro for #TeamRetinaUK in Tanzania in October 2026?

• Walks & Treks
• United Kingdom

Face your fears and support Retina UK with a charity skydive this summer!

• Extreme Challenges
• United Kingdom

Are you ready to sign up for a spooky skydive and face your fears for Retina UK?

• Extreme Challenges
• United Kingdom

Welcome to the winter edition of Look Forward. It’s packed full of news from our Conferences, the latest research news and an interview with Hassina Zeriri, one of our funded PhD students.

We have also included details of lots of ways you can get involved with Retina UK over the coming months, along with some suggested festive fundraising for the Christmas period.

• Look Forward
• Audio
• Written

Tuesday 12 May 2026, 7.00pm - 8.00pm - via Zoom - Please come and join facilitator Stuart Francis and our new South Wales Peer Support Group where we are delighted to welcome guest speaker Becs Harris, Wellbeing Service Manager at Sight Cymru.

• Local Peer Support Group

It has recently been announced that Meira-GTx, who originally developed bota-vec and collaborated with J&J during its early clinical trials, have entered into an asset purchase agreement with J&J to acquire bota-vec and progress the program towards global regulatory filings for approval.

• News
• Retinitis pigmentosa

The BBC covered a story on Monday 24 May about optogenetics partially restoring the sight of a man living with retinitis pigmentosa in France.

• News

Biotechnology company ProQR has announced encouraging results from its phase 1/2 clinical trial of an innovative treatment for sight loss caused by faults in a specific section of the USH2A gene.

• News

The FDA has given Ocugen permission to start their phase 3 gene therapy clinical trial for retinitis pigmentosa (RP).

• News
• Retinitis pigmentosa